SCHEMBL50526

SCHEMBL50526

CC1(C)c2ccsc2-c2sccc21

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CES1 P23141 1/20 0.35
CYP2A6 P11509 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17068313 0.84 CES1 (0.33) CES1CYP2A6
SCHEMBL22807704 0.83 CES1 (0.35) CES1CYP2A6
SCHEMBL13641370 0.80
SCHEMBL12758151 0.80 PTPRC (0.38) CES1
SCHEMBL17108437 0.79 CES1 (0.33) CES1
SCHEMBL22503337 0.79 CES1 (0.30) CES1
SCHEMBL15763739 0.79 CES1 (0.43) CES1
SCHEMBL19470533 0.78
SCHEMBL12565277 0.77
SCHEMBL50922 0.76 CYP2A6 (0.33) CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11555820-B2 Nanohoop compounds for use in biotechnology and methods of making and using the same UNIVERSITY OF OREGON (US) 2023-01-17 US claimed
US-10934290-B2 Donor-acceptor nanohoop compounds and methods of making and using the same UNIVERSITY OF OREGON (US) 2021-03-02 US claimed
US-20180290952-A1 HALOGENATED NANOHOOP COMPOUNDS AND METHODS OF MAKING AND USING THE SAME UNIVERSITY OF OREGON (US) 2018-10-11 US claimed
US-20160372684-A1 DONOR-ACCEPTOR NANOHOOP COMPOUNDS AND METHODS OF MAKING AND USING THE SAME UNIVERSITY OF OREGON 2016-12-22 US claimed
US-20250250262-A1 ORGANIC COMPOUND, OPTO-ELECTRONIC DEVICE INCLUDING THE SAME, AND ELECTRONIC DEVICE AND ELECTRONIC APPARATUS INCLUDING THE OPTO-ELECTRONIC DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2025-08-07 US disclosed
WO-2024067923-A1 CHEMICAL COMPOSITION, OPTOELECTRONIC COMPONENT COMPRISING AT LEAST ONE CHEMICAL COMPOSITION OF THIS TYPE, AND USE OF AT LEAST ONE CHEMICAL COMPOSITION OF THIS TYPE IN AN OPTOELECTRONIC COMPONENT HELIATEK GMBH (DE) 2024-04-04 WO disclosed
US-20230227475-A1 Asymmetric Fused Aromatic Ring Derivative Containing Sulfonyl Group, Use Thereof, Hydrogen Production Device and Optoelectronic Component NATIONAL TSING HUA UNIVERSITY (TW) 2023-07-20 US disclosed
WO-2023012366-A1 PHOTORESPONSIVE NONFULLERENE ACCEPTORS OF THE A-D-A'-D-A TYPE FOR USE IN OPTOELECTRONIC DEVICES CAMBRIDGE DISPLAY TECHNOLOGY LTD. (GB) 2023-02-09 WO disclosed
WO-2023012365-A1 PHOTORESPONSIVE ASYMMETRIC NONFULLERENE ACCEPTORS OF THE A-D-A'-D-A TYPE FOR USE IN OPTOELECTRONIC DEVICES CAMBRIDGE DISPLAY TECHNOLOGY LTD. (GB) 2023-02-09 WO disclosed
WO-2023012364-A1 PHOTORESPONSIVE NONFULLERENE ACCEPTORS OF THE A-D-A'-D-A TYPE FOR USE IN OPTOELECTRONIC DEVICES CAMBRIDGE DISPLAY TECHNOLOGY LTD. (GB) 2023-02-09 WO disclosed
WO-2023012363-A1 PHOTOACTIVE NONFULLERENE ACCEPTORS OF THE A-D-A'-D-A TYPE FOR USE IN OPTOELECTRONIC DEVICES CAMBRIDGE DISPLAY TECHNOLOGY LTD. (GB) 2023-02-09 WO disclosed
US-11555820-B2 Nanohoop compounds for use in biotechnology and methods of making and using the same UNIVERSITY OF OREGON (US) 2023-01-17 US disclosed
US-20110313175-A1 4, 4' DISUBSTITUTED 4H-CYCLOPENTADITHIOPHENE AND NEW METHODS FOR SYNTHESISING THE SAME UNIVERSITEIT HASSELT (BE) 2011-12-22 US disclosed
US-20110313175-A1 4, 4' DISUBSTITUTED 4H-CYCLOPENTADITHIOPHENE AND NEW METHODS FOR SYNTHESISING THE SAME UNIVERSITEIT HASSELT (BE) 2011-12-22 US disclosed
EP-2397475-A1 4, 4' disubstituted 4H-cyclopentadithiophene and new methods for synthesising the same IMEC (BE) 2011-12-21 EP disclosed
US-20110147725-A1 SULFONATED POLYTHIOPHENES COMPRISING FUSED RING REPEAT UNITS PLEXTRONICS, INC. 2011-06-23 US disclosed
US-20110147725-A1 SULFONATED POLYTHIOPHENES COMPRISING FUSED RING REPEAT UNITS PLEXTRONICS, INC. 2011-06-23 US disclosed
US-20090042227-A1 AMINO(OLIGO)THIOPHENE DYES, PREPARATION THEREOF, AND OPTICAL METHODS OF USE NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2009-02-12 US disclosed
US-20090042227-A1 AMINO(OLIGO)THIOPHENE DYES, PREPARATION THEREOF, AND OPTICAL METHODS OF USE NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2009-02-12 US disclosed
US-20090042227-A1 AMINO(OLIGO)THIOPHENE DYES, PREPARATION THEREOF, AND OPTICAL METHODS OF USE NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10934290-B2 Donor-acceptor nanohoop compounds and methods of making and using the same NCL, NQO1, NDUFV2 CES1 3849/4885CYP2A6 2544/4885
US-20230227475-A1 Asymmetric Fused Aromatic Ring Derivative Containing Sulfonyl Group, Use Thereof, Hydrogen Production Device and Optoelectronic Component AHR, STS, HAT1 CES1 3329/4885CYP2A6 1551/4885
US-20250250262-A1 ORGANIC COMPOUND, OPTO-ELECTRONIC DEVICE INCLUDING THE SAME, AND ELECTRONIC DEVICE AND ELECTRONIC APPARATUS INCLUDING THE OPTO-ELECTRONIC DEVICE OR10J3, OR51E2, OCIAD1 CES1 2430/4885CYP2A6 1002/4885
US-20160372684-A1 DONOR-ACCEPTOR NANOHOOP COMPOUNDS AND METHODS OF MAKING AND USING THE SAME NCL, NQO1, NDUFV2 CES1 3849/4885CYP2A6 2544/4885
US-20180290952-A1 HALOGENATED NANOHOOP COMPOUNDS AND METHODS OF MAKING AND USING THE SAME NBAS, VDAC1, HDHD5 CES1 4473/4885CYP2A6 2951/4885
US-20090042227-A1 AMINO(OLIGO)THIOPHENE DYES, PREPARATION THEREOF, AND OPTICAL METHODS OF USE NLN, NME4, OAT CES1 4726/4885CYP2A6 4007/4885
US-20110313175-A1 4, 4' DISUBSTITUTED 4H-CYCLOPENTADITHIOPHENE AND NEW METHODS FOR SYNTHESISING THE SAME DDT, NISCH, DBH CES1 3296/4885CYP2A6 628/4885
US-11555820-B2 Nanohoop compounds for use in biotechnology and methods of making and using the same LNPEP, MRPL21, CD44 CES1 1657/4885CYP2A6 3413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.